Welcome and Opening Remarks

Amy Gutmann, Ph.D. Commission Chair
James Wagner, Ph.D. Commission Vice-Chair

Session 1: Historical Investigation – Research Details

Commission Members

Session 2: Historical Investigation – Ethics Standards and Practices

Commission Members

Day 2 Opening Remarks

Amy Gutman, Ph.D.
James Wagner, Ph.D.

Session 3: Human Subjects Protection Reform

Ezekiel J. Emanuel, M.D., Ph. D.
Former Chief, Clinical Center Department of Bioethics, National Institutes of Health

Session 4: International Research Panel Results and Discussion

Nelson Michael, M.D., Ph.D. Commission Member
Christine Grady, R.N., Ph.D. Commission Member

Session 5: Community Engagement – Needs, Models and U.S. Actions

Carletta Tilousi
Member, Havasupai Tribal Council Havasupai Tribe

Mitchell Warren
Executive Director, AVAC: Global Advocacy for HIV Prevention

Roger I. Glass, M.D., Ph.D.
Director, Fogarty International Center; Associate Director for International Research, National Institutes of Health

Session 6: Staff Report on Current Scientific Studies Supported by the Federal Government

Jeremy Sugarman, M.D., M.P.H., M.A. Senior Advisor

Michelle Groman, J.D. Senior Policy & Research Analyst

Session 7: Trial Design and International Standards

Ruth Macklin, Ph.D.
Professor of Bioethics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine

Robert Temple, M.D.
Deputy Center Director for Clinical Science, Center for Drug Evaluation and Research; Acting Director, Office of Drug Evaluation I, U.S. Food and Drug Administration (FDA)

Concluding Remarks

Amy Gutmann, Ph.D.
James Wagner, Ph.D.